Parthenon Capital Makes Strategic Investment in Momentum Life Sciences
July 2, 2026
Momentum Life Sciences announced a strategic growth investment from Parthenon Capital; financial terms were not disclosed. The capital is intended to accelerate Momentum’s growth strategy and pursue strategic acquisitions across the specialty-therapy commercialization ecosystem focused on patient initiation and adherence.
- Buyers
- Parthenon Capital
- Targets
- Momentum Life Sciences
- Industry
- Healthcare Services
- Location
- Indiana, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.